Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a handoff plan help teens with chronic illness take charge of their care?

NCT ID NCT07145671

Knowledge-focused Sponsor: Universiteit Antwerpen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 11, 2026 · Last updated Sep 11, 2026

Summary

Researchers are testing a transition program for 17-year-olds with type 1 diabetes, asthma, or obesity who are preparing to move from pediatric to adult healthcare. The program includes a consultation with the teen and family, a solo visit where the teen completes a readiness checklist, and a joint meeting with both pediatric and adult providers. The study measures whether the program improves readiness to transition, patient empowerment, and cost-effectiveness.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a structured transition program with pediatric and adult healthcare providers
What this could lead to
If it works, this program could give hospitals a practical model for helping young people with chronic conditions take charge of their own care as adults.
What could go wrong
The study is small and tests feasibility, not whether health outcomes improve. Results may not apply to other hospitals or conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

65 people

The number who actually took part.

Started

Mar 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

16 to 19 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: For participants in the intervention group (IG): * 17 years old; * diagnosed with type 1 diabetes, asthma and/or obesity; * who had at least one pediatric outpatient visit, prior to inclusion, in one of both hospitals within the past 12 months; * are Dutch speaking; * planned to transfer to adult care within the next 12 months. For participants in the control group (CG): * age 17,5 and 18 years old, as the control period has a shorter duration (4 months vs. 12 months) * diagnosed with type 1 diabetes, asthma and/or obesity; * who had at least one pediatric outpatient visit, prior to inclusion, in one of both hospitals within the past 12 months; * are Dutch speaking; * planned to transfer to adult care within the next 12 months. Exclusion criteria: Applicable for both CG and IG: \- patients with severe mental, cognitive or neurological problems will be excluded

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Asthma are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma Obesity obesity disorder type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Asthma Obesity Type 1 diabetes mellitus

Contacts and locations

Locations

  • Ghent University Hospital

    Ghent, 9000, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.